Trials / Sponsors / F-star Therapeutics, Inc.
F-star Therapeutics, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepat Hepatitis B, HBV, Hepatitis B, Chronic | Phase 2 | 2019-10-10 |
| Terminated | Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Inf Hepatitis B, HBV, Hepatitis B, Chronic | Phase 2 | 2019-06-18 |
| Terminated | Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients HBV, Hepatitis B, Hepatitis B, Chronic | Phase 2 | 2019-04-11 |
| Completed | A Fixed-Sequence, Drug-Drug Interaction Study Between Multiple Oral Doses of Inarigivir Soproxil and a Single Drug Interaction Potentiation | Phase 1 | 2018-05-07 |
| Completed | A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With C Hepatitis B, Hepatitis, Viral | Phase 2 | 2016-05-01 |